Generics BulletinWith 180 days of market exclusivity, Apotex has launched the first US generic version of Novartis’ Tasigna (nilotinib) blockbuster treatment for chronic phase and accelerated phase Philadelphia chromo
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. CytomX, Amgen Decision Follows January
Generics BulletinApotex has further diversified its offerings by acquiring CanPrev, a Canadian provider of vitamins, supplements, and other natural health products, in a deal that the firm says introduces it into the